Mercer Global Advisors
ALDX icon

Mercer Global Advisors’s Aldeyra Therapeutics ALDX Stock Holding History

Mercer Global Advisors’s Portfolio ALDX Stock Details ALDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$78.6K Sell
36,901
-841
-2% -$1.45K ﹤0.01% 3471
2026
Q1 		$63.8K Buy
37,742
+27,171
+257% +$119K ﹤0.01% 3100
2025
Q4 		$54.8K Sell
10,571
-3,814
-27% -$19.6K ﹤0.01% 2785
2025
Q3 		$75.1K Buy
+14,385
New +$75K ﹤0.01% 2561

Other funds holding ALDX

KCM
Knoll Capital Management Miami, Florida $214M AUM 62.74% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
KCM
Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Mercer Global Advisors's ALDX Position: Q2 2026 in Review

Mercer Global Advisors reduced its Aldeyra Therapeutics (ALDX) stake by 2.2% in Q2 2026, selling an estimated $1.45K and leaving 36,901 shares worth $78.6K. The position accounts for ﹤0.01% of the portfolio, ranked #3471.

Mercer Global Advisors first reported a position in ALDX in Q3 2025 and has held it in 4 quarters since. 107 funds tracked by Wall St. Rank hold ALDX as of Q2 2026.

  • Mercer Global Advisors held 36,901 shares of Aldeyra Therapeutics worth $78.6K as of Q2 2026.
  • Mercer Global Advisors sold 841 Aldeyra Therapeutics shares in Q2 2026, an estimated $1.45K.
  • Aldeyra Therapeutics made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #3471 holding.
  • Mercer Global Advisors first reported a position in Aldeyra Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • 107 funds tracked by Wall St. Rank held Aldeyra Therapeutics as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.